PCRX PharmaCorp Rx Inc.

0.2831USD0.4050 CAD · TSXV+1.25%Mkt Cap: 55.77M USDP/E: —

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health produc…

Key Statistics

Company
Market Cap55.77M USD
Enterprise Value35.87M USD
Revenue (TTM)19.16M USD
Gross Profit5.80M USD
Net Income (TTM)-994.08K USD
Revenue/Share0.13 USD
Last Price0.2831 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryCA
SectorHealthcare
IndustryPharmaceutical Retailers
ISINCA71714X1050
Valuation
P/E (Trailing)—
P/E (Forward)17.36
PEG—
EV/EBITDA-196.18
EV/Revenue1.87
P/S2.91
P/B1.34
EPS (TTM)-0.0070 USD
EPS (Forward)0.02 USD
52W Range
0.262115% of range0.4054
52W High0.4054 USD
52W Low0.2621 USD
Profitability
Gross Margin39.72%
Oper. Margin-4.79%
EBITDA Margin-0.95%
Profit Margin-6.81%
ROE-2.74%
ROA-2.17%
ROIC-4.00%
ROCE-2.07%
Growth
Revenue Growth75.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.40M USD
CapEx (TTM)1.52M USD
FCF Margin-1.64%
FCF Yield-0.56%
Net Debt-13.69M USD
Net Debt/EBITDA74.89
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio7.36
Quick Ratio6.53
Book Value/Sh0.21 USD
Cash/Share0.10 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.4660 USD
Upside (mean)+64.6%
Target Range0.4194 USD – 0.4893 USD
0.4194+64.6% to mean0.4893
# Analysts3
Ownership
Shares Out.196.98M
Float158.73M
Insiders8.31%
Institutions11.22%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short4.25K
Short (prev mo.)8.90K
Technical
SMA 500.2871 (-1.4%)
SMA 2000.3191 (-11.3%)
Beta-3.95
S&P 52W Chg12.00%
Avg Vol (30d)153.32K
Avg Vol (10d)151.47K
Technical Indicators
RSI (14)48.1
MACD-0.0027
MACD Signal-0.0035
MACD Hist.+0.0008
BB Upper0.2950 USD
BB Middle0.2843 USD
BB Lower0.2736 USD
BB Width7.53%
ATR (14)0.0110 USD
Vol Ratio (20d)0.46x

About PharmaCorp Rx (CVE: PCRX)

›

PharmaCorp Rx (CVE: PCRX) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 5 employees.

The shares were at 0.4050 CAD on 19 November 2026, down 4.7% over 52 weeks. Its 52-week range is 0.3750 CAD to 0.5800 CAD: the price is 30.2% below the high and 8.0% above the low.

Its market capitalisation is 79.78M CAD.

PharmaCorp Rx reports return on equity of -2.7%, an operating margin of -4.8% and revenue up 75.8% year over year.

It holds more cash than debt, a net cash position of 19.59M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 0.6667 CAD is 64.6% above the current price. The next earnings report is expected on 3 December 2026.